What are the latest advances in Anosmia?

Recent advances in anosmia research are shifting from passive observation to active neuro-regeneration, with significant progress in "smell training" protocols and investigations into anti-inflammatory biologics. While no single "cure" exists, clinical trials are currently exploring the use of intranasal corticosteroids, platelet-rich plasma (PRP) injections, and neurotrophic factors to help restore olfactory function in patients with anosmia.

What are the most promising research directions for anosmia?

Current research into anosmia is heavily focused on the regenerative capacity of the olfactory epithelium. Scientists are investigating how to stimulate the basal stem cells within the nose to differentiate into mature olfactory sensory neurons. A primary area of study involves "smell training," a structured therapeutic approach where patients repeatedly expose themselves to specific scents to encourage neuroplasticity in the olfactory bulb. Research has demonstrated that consistent, long-term olfactory training can lead to measurable improvements in odor detection and identification for many individuals living with anosmia.

Are there new pharmacological treatments or biologics for anosmia?

Medical researchers are evaluating several novel interventions for anosmia, particularly those targeting post-viral olfactory loss. Some of the most notable research areas include:

• Intranasal Vitamin A: Studies are testing whether topical Vitamin A can promote the regeneration of olfactory receptor neurons.


• Anti-inflammatory Biologics: Researchers are exploring whether monoclonal antibodies, which reduce inflammation in the nasal passages, may assist patients whose anosmia is complicated by chronic rhinosinusitis.


• Systemic Corticosteroids: While controversial due to potential side effects, short courses of oral steroids are being studied to reduce inflammation in the olfactory cleft.


• Platelet-Rich Plasma (PRP): Early-stage clinical trials are investigating the efficacy of injecting a patient's own concentrated platelets into the nasal cavity to stimulate tissue repair.

How is research into anosmia evolving through clinical trials?

Clinical trials for anosmia are increasingly utilizing standardized diagnostic tools like the University of Pennsylvania Smell Identification Test (UPSIT) to quantify patient outcomes. Because anosmia can result from diverse causes—including trauma, viral infection, or congenital factors—researchers are working to categorize patients into specific phenotypes to ensure precision medicine approaches are applied correctly. The global research community, led by institutions like the Monell Chemical Senses Center and various international smell and taste disorder consortia, is currently recruiting participants to better understand the neurological pathways involved in smell recovery.

How can patients find and participate in clinical trials?

Participating in clinical research is a vital way to advance the science of smell loss. Patients interested in contributing to anosmia research should follow these steps:

• Visit ClinicalTrials.gov and search using the term "anosmia" or "olfactory dysfunction" to see active recruitment lists.


• Consult with an Otorhinolaryngologist (ENT specialist) who specializes in rhinology to discuss if you meet the inclusion criteria for specific studies.


• Connect with the 513 members of the DiseaseMaps.org community who are living with anosmia to share information about active trials and patient experiences.


• Monitor updates from organizations like AbScent or Fifth Sense, which often partner with research institutions to facilitate patient enrollment in studies.

Next steps

• Schedule an appointment with an Otorhinolaryngologist to perform a formal olfactory threshold test.


• Begin a structured smell training program using essential oils (e.g., rose, lemon, clove, and eucalyptus) twice daily.


• Join the DiseaseMaps.org platform to track your symptoms and connect with others navigating life with anosmia.


• Keep a symptom diary to document any subtle changes in your ability to detect environmental odors, which can be useful for your clinical team.

Medical disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of your physician regarding any medical condition.

References

• National Institutes of Health (NIH) - Genetic and Rare Diseases Information Center (GARD)


• Monell Chemical Senses Center - Olfactory Research Database


• Orphanet - Rare Disease Information Portal


• ClinicalTrials.gov - Registry of clinical trials for olfactory loss